Focused Investors LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 507,200 shares of the healthcare conglomerate’s stock after selling 15,000 shares during the period. UnitedHealth Group comprises approximately 4.2% of Focused Investors LLC’s holdings, making the stock its 14th biggest holding. Focused Investors LLC owned about 0.05% of UnitedHealth Group worth $99,335,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of the company. BlackRock Inc. raised its holdings in shares of UnitedHealth Group by 1.2% in the second quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock valued at $12,873,786,000 after buying an additional 796,654 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of UnitedHealth Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after buying an additional 1,588,516 shares during the last quarter. FMR LLC raised its holdings in shares of UnitedHealth Group by 2.1% in the second quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock valued at $10,402,371,000 after buying an additional 1,168,324 shares during the last quarter. Alliancebernstein L.P. raised its holdings in shares of UnitedHealth Group by 2.3% in the second quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock valued at $1,466,104,000 after buying an additional 174,290 shares during the last quarter. Finally, TIAA CREF Investment Management LLC raised its holdings in shares of UnitedHealth Group by 3.9% in the second quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock valued at $1,090,720,000 after buying an additional 223,524 shares during the last quarter. Institutional investors own 85.97% of the company’s stock.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) opened at $222.04 on Wednesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The company has a market capitalization of $214,958.56, a PE ratio of 23.11, a PEG ratio of 1.65 and a beta of 0.66. UnitedHealth Group Incorporated has a 52 week low of $156.09 and a 52 week high of $231.77.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. UnitedHealth Group’s revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the business posted $2.17 EPS. sell-side analysts predict that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were paid a $0.75 dividend. The ex-dividend date was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.35%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.

A number of research analysts recently issued reports on the company. Jefferies Group reaffirmed a “buy” rating and issued a $248.00 price target on shares of UnitedHealth Group in a report on Friday, December 1st. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Friday, December 1st. Sanford C. Bernstein lifted their price target on UnitedHealth Group from $219.00 to $246.00 and gave the company an “outperform” rating in a report on Friday, December 1st. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th. Finally, Raymond James Financial reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 6th. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and an average target price of $224.56.

In other news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the sale, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 34,630 shares of company stock valued at $7,669,416. 0.89% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION NOTICE: This news story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/20/unitedhealth-group-incorporated-unh-stake-lowered-by-focused-investors-llc.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.